Lewis Asset Management, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 2004520 LAFAYETTE, CA

Position in VKTX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,605,477

+$519,989 QoQ

Shares Held

66,790

+4.2% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

1.21%

of 13F equity value

Holder Rank

#96

of 432 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Lewis Asset Management, LLC holds $4,040,524 across 4 Biotechnology names. VKTX ranks #1 (64.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc. This page	66,790	$2,605,477
2	CRNX	Crinetics Pharmaceuticals, Inc.	24,325	$910,241
3	NTLA	Intellia Therapeutics, Inc.	18,270	$309,128
4	DFTX	Definium Therapeutics, Inc.	4,585	$215,678

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,605,477	66,790	+4.2%	Shares	Sole	2026-07-21
2026-03-31	$2,085,488	64,090	+3.6%	Shares	Sole	2026-04-21
2025-12-31	$2,177,290	61,890	+10.7%	Shares	Sole	2026-01-15
2025-09-30	$1,469,840	55,930	+26.9%	Shares	Sole	2025-10-20
2025-06-30	$1,167,590	44,060	+0.9%	Shares	Sole	2025-07-14
2025-03-31	$1,054,751	43,675	+5.8%	Shares	Sole	2025-05-05
2024-12-31	$1,660,906	41,275	+35.8%	Shares	Sole	2025-01-23
2024-09-30	$1,924,307	30,395	+14.9%	Shares	Sole	2024-10-31
2024-06-30	$1,401,849	26,445	+64.0%	Shares	Sole	2024-07-30
2024-03-31	$1,322,250	16,125	—	Shares	Sole	2024-05-01
No filing history on record for this holder in this stock.